| Literature DB >> 32301740 |
Yan Li1, Shan Ye1, Yidong Zhou1, Feng Mao1, Hailing Guo1, Yan Lin1, Xiaohui Zhang1, Songjie Shen1, Na Shi1, Xiaojie Wang1, Qiang Sun1.
Abstract
BACKGROUND: The internet allows patients to easily look for health information. However, how Chinese patients with breast cancer use the internet has rarely been investigated, and there is a scarcity of information about the influence of internet use on survival.Entities:
Keywords: breast cancer; breast conserving therapy; disease-free survival; internet; online information; satisfaction level
Year: 2020 PMID: 32301740 PMCID: PMC7316180 DOI: 10.2196/16768
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Patient characteristics within subgroups.
| Characteristic | Web group (n=477) | Nonweb group (n=496) | ||
| Age (years), mean (SD) | 43.81 (11.73) | 50.49 (14.00) | <.001 | |
|
| .01 | |||
|
| < high school | 376 (78.8) | 356 (71.8) |
|
|
| < high school | 101 (21.2) | 140 (28.2) |
|
|
| <.001 | |||
|
| Urban | 278 (58.3) | 211 (42.5) |
|
|
| Rural | 199 (41.7) | 285 (57.5) |
|
|
| .14 | |||
|
| I | 244 (51.2) | 224 (45.2) |
|
|
| II | 141 (29.6) | 157 (31.7) |
|
|
| III | 92 (19.3) | 115 (23.2) |
|
|
| .79 | |||
|
| Luminal A | 223 (46.8) | 246 (49.6) |
|
|
| Luminal B | 112 (23.5) | 113 (22.8) |
|
|
| Triple-negative breast cancer | 95 (19.9) | 95 (19.2) |
|
|
| HER2a-positive | 47 (9.9) | 42 (8.5) |
|
|
| .52 | |||
|
| Low | 225 (47.2) | 251 (50.6) |
|
|
| Medium | 125 (26.2) | 126 (25.4) |
|
|
| High | 127 (26.6) | 119 (24.0) |
|
|
| .047 | |||
|
| Breast conserving therapy | 284 (59.5) | 264 (53.2) |
|
|
| Mastectomy | 193 (40.5) | 232 (46.8) |
|
aHER2: human epidermal growth factor receptor 2.
Multivariate logistic analysis of the association between web-based information seeking and patient characteristics.
| Characteristic | Web use (n=477), n (%) | Odds ratio (95% CI) | ||
| Age | N/Aa | 0.95 (0.94-0.97) | <.001 | |
|
| ||||
|
| < high school (reference) | 101 (41.9) | N/A | N/A |
|
| < high school | 376 (51.4) | 1.37 (1.01-1.86) | .04 |
|
| ||||
|
| Rural (reference) | 199 (41.1) | N/A | N/A |
|
| Urban | 278 (56.9) | 0.78 (0.53-1.14) | .197 |
|
| ||||
|
| I (reference) | 244 (52.1) | N/A | N/A |
|
| II | 141 (47.3) | 0.81 (0.59-1.09) | .16 |
|
| III | 92 (44.4) | 0.73 (0.53-1.03) | .08 |
|
| ||||
|
| Luminal A (reference) | 223 (47.6) | N/A | N/A |
|
| Luminal B | 112 (49.8) | 1.01 (0.71-1.41) | .97 |
|
| Triple-negative breast cancer | 95 (50.0) | 1.04 (0.73-1.48) | .83 |
|
| HER2b-positive | 47 (52.8) | 1.20 (0.75-1.93) | .45 |
|
| ||||
|
| Low (reference) | 225 (47.3) | N/A | N/A |
|
| Medium | 125 (49.8) | 1.03 (0.75-1.42) | .86 |
|
| High | 127 (51.6) | 1.13 (0.82-1.56) | .45 |
|
| ||||
|
| Mastectomy (reference) | 193 (45.4) | N/A | N/A |
|
| Breast conserving therapy | 284 (51.8) | 1.35 (1.04-1.77) | .03 |
aN/A: not applicable.
bHER2: human epidermal growth factor receptor 2.
Details of patients’ web-based breast cancer information-searching behavior.
| Variables | Web-using participants (n=477), n (%) | |
|
| ||
|
| Computer (desktop, laptop, tablets) | 178 (37.3) |
|
| Mobile phones | 203 (42.6) |
|
| Both | 96 (20.1) |
|
| ||
|
| Baidu | 350 (73.4) |
|
| 318 (66.7) | |
|
| Professional websites | 213 (44.7) |
|
| Discussion forums | 129 (27.0) |
|
| Others | 147 (30.8) |
|
| ||
|
| Satisfied | 214 (44.9) |
|
| Unsatisfied | 263 (55.1) |
Figure 1Kaplan-Meier survival curves of disease-free survival by web usage.
Figure 2Kaplan-Meier survival curves of disease-free survival (DFS) according to web usage and satisfaction level of internet information.
Cox proportional hazards regression model analysis of disease-free survival.
| Factor | Hazard ratio (95% CI) | ||
| Age (continuous) | 1.00 (0.98-1.03) | .54 | |
|
| |||
|
| I (reference) | N/Aa | N/A |
|
| II | 1.20 (0.57-2.51) | .63 |
|
| III | 1.86 (0.90-3.82) | .09 |
|
| |||
|
| Luminal A (reference) | N/A | N/A |
|
| Luminal B | 2.12 (0.86-5.23) | .10 |
|
| Triple-negative breast cancer | 3.79 (1.63-8.77) | .002 |
|
| HER2b-positive | 7.11 (2.89-17.48) | <.001 |
|
| |||
|
| Mastectomy (reference) | N/A | N/A |
|
| Breast conserving therapy | 1.85 (0.98-3.48) | .06 |
|
| |||
|
| No web (reference) | N/A | N/A |
|
| Web use-unsatisfied | 0.99 (0.51-1.96) | .99 |
|
| Web use-satisfied | 0.26 (0.08-0.88) | .03 |
aN/A: not applicable.
bHER2: human epidermal growth factor receptor 2.